- Home
- TSHA vs PKE Comparison
TSHA vs PKE Comparison
Compare TSHA & PKE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TSHA
- PKE
- Stock Information
- Founded
- TSHA 2019
- PKE 1954
- Country
- TSHA United States
- PKE United States
- Employees
- TSHA N/A
- PKE N/A
- Industry
- TSHA Biotechnology: Pharmaceutical Preparations
- PKE Military/Government/Technical
- Sector
- TSHA Health Care
- PKE Industrials
- Exchange
- TSHA Nasdaq
- PKE Nasdaq
- Market Cap
- TSHA 356.7M
- PKE 285.7M
- IPO Year
- TSHA 2020
- PKE N/A
- Fundamental
- Price
- TSHA $1.38
- PKE $13.41
- Analyst Decision
- TSHA Strong Buy
- PKE
- Analyst Count
- TSHA 8
- PKE 0
- Target Price
- TSHA $6.63
- PKE N/A
- AVG Volume (30 Days)
- TSHA 1.6M
- PKE 45.4K
- Earning Date
- TSHA 05-13-2025
- PKE 01-14-2025
- Dividend Yield
- TSHA N/A
- PKE 3.73%
- EPS Growth
- TSHA N/A
- PKE N/A
- EPS
- TSHA N/A
- PKE 0.36
- Revenue
- TSHA $8,333,000.00
- PKE $61,420,000.00
- Revenue This Year
- TSHA N/A
- PKE N/A
- Revenue Next Year
- TSHA N/A
- PKE N/A
- P/E Ratio
- TSHA N/A
- PKE $37.44
- Revenue Growth
- TSHA N/A
- PKE 15.45
- 52 Week Low
- TSHA $1.17
- PKE $11.96
- 52 Week High
- TSHA $4.32
- PKE $16.62
- Technical
- Relative Strength Index (RSI)
- TSHA 34.93
- PKE 42.59
- Support Level
- TSHA $1.59
- PKE $13.64
- Resistance Level
- TSHA $1.87
- PKE $14.27
- Average True Range (ATR)
- TSHA 0.15
- PKE 0.34
- MACD
- TSHA -0.01
- PKE 0.02
- Stochastic Oscillator
- TSHA 24.36
- PKE 13.13
About TSHA Taysha Gene Therapies Inc.
Taysha Gene Therapies Inc is a patient-centric gene therapy company to eradicate monogenic CNS disease. It is focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the CNS in both rare and large patient populations. The company develops and commercializes transformative gene therapy treatments. Its product pipeline includes, TSHA-102 which is a is a self-complementary intrathecally delivered AAV9 gene transfer therapy in clinical evaluation for Rett syndrome.
About PKE Park Aerospace Corp.
Park Aerospace Corp designs develop and manufactures engineered, advanced composite materials and composite structures and assemblies and low-volume tooling for the aerospace markets and prototype tooling for such structures and assemblies. Geographically, the company derives a majority of revenue from North America and also has a presence in a company operates its business in Asia and Europe. It offers advanced composite Prepregs for Aircraft Structures and Interiors, Sigma Strut and Alpha Strut.